Imaging Recommendations for Diagnosis, Staging, and Management of Sinonasal Tumors

Abstract

Sinonasal tumors are a relatively rare and heterogeneous group of tumors. Owing to their nonspecific presentation and rarity, they can be potentially overlooked resulting in delayed diagnosis and management, and increased patient morbidity. Imaging is crucial for the detection, staging, surgical planning, follow-up as well as surveillance of sinonasal masses, wherein computed tomography (CT) and magnetic resonance imaging (MRI) play complementary roles. CT is better at depicting bony changes, while MRI is useful for delineating the extent of soft tissue lesion, detect perineural, intracranial, or intraorbital spread as well as differentiate trapped sinus secretions from tumor tissue. Other modalities like fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) and arteriography can be selectively employed. FDG-PET is useful for metastatic workup and detection of residual/ recurrent disease. Arteriography and endovascular image-guided interventions are useful to delineate supply of vascular tumors and perform preoperative embolization. A systematic evidence-based approach to a possible case of sinonasal tumor can go a long way in streamlining the detection and management of these tumors, while optimizing the use of available healthcare resources.

Keywords

guidelines - malignancy - tumors - neoplasms - paranasal sinus - radiology - sinonasal imaging

Authors' Contributions

ASB, GMNI, SM contributed in the concept, design, literature search, manuscript preparation, editing, and review. AG, RK, AS, AT, and AI contributed to the manuscript editing and review.

The authors hereby declare to have read and given their approval for this manuscript.

Publikationsverlauf

Artikel online veröffentlicht:
06. März 2023

• References

• 1 Eggesbø HB. Imaging of sinonasal tumours. Cancer Imaging 2012; 12: 136-152
• 2 McCollister KB, Hopper BD, Michel MA. Sinonasal neoplasms: Update on classification, imaging features, and management. Appl Radiol 2015; 44 (12) 7-15
• 3 Llorente JL, López F, Suárez C, Hermsen MA. Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances. Nat Rev Clin Oncol 2014; 11 (08) 460-472
• 4 Haerle SK, Gullane PJ, Witterick IJ, Zweifel C, Gentili F. Sinonasal carcinomas: epidemiology, pathology, and management. Neurosurg Clin N Am 2013; 24 (01) 39-49
• 5 Sen S, Chandra A, Mukhopadhyay S, Ghosh P. Imaging approach to sinonasal neoplasms. Neuroimaging Clin N Am 2015; 25 (04) 577-593
• 6 Lund VJ, Clarke PM, Swift AC, McGarry GW, Kerawala C, Carnell D. Nose and paranasal sinus tumours: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 2016; 130 (S2): S111-S118
• 7 Satarkar RN, Srikanth S. Tumors and tumor-like conditions of the nasal cavity, paranasal sinuses, and nasopharynx: a study of 206 cases. Indian J Cancer 2016; 53 (04) 478-482
• 8 Olliff J, Richards P, Connor S. et al. Head and Neck Cancers. In: Nicholson T. ed. Recommendations for Cross-Sectional Imaging in Cancer Management. 2nd ed.. London: The Royal College of Radiologists; 2014
• 9 National Comprehensive Cancer Network. Head and Neck Cancers (Version 1.2022). Accessed November 11, 2022, at: http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf
• 10 American College of Radiology. ACR Appropriateness Criteria Sinonasal Disease (2021 revision). Accessed November 11, 2022, at: http://acsearch.acr.org/docs/69502/narrative
• 11 Genden EM, Rinaldo A, Bradley PJ. et al. Referral guidelines for suspected cancer of the head and neck. Auris Nasus Larynx 2006; 33 (01) 1-5
• 12 Hawkins RJ, Wang EE, Leake JL. Preventive health care, 1999 update: prevention of oral cancer mortality. The Canadian Task Force on Preventive Health Care. J Can Dent Assoc 1999; 65 (11) 617
• 13 Prout MN, Sidari JN, Witzburg RA, Grillone GA, Vaughan CW. Head and neck cancer screening among 4611 tobacco users older than forty years. Otolaryngol Head Neck Surg 1997; 116 (02) 201-208
• 14 Calabrese L, Tradati N, Nickolas TL. et al. Cancer screening in otorhinolaryngology. Oral Oncol 1998; 34 (01) 1-4
• 15 Richards PS, Peacock TE. The role of ultrasound in the detection of cervical lymph node metastases in clinically N0 squamous cell carcinoma of the head and neck. Cancer Imaging 2007; 7: 167-178
• 16 Guidelines Version NCG. 3 Management of Head and Neck Cancers. Accessed November 11, 2022, at: http://tmc.gov.in/ncg/docs/PDF/DraftGuidelines/Headandneck/Management_of_HN_cancer_Ver.3-AT-15Nov19.pdf
• 17 Amin MB, Edge SB, Greene FL. et al, eds. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer, 2017
• 18 Higgins TS, Thorp B, Rawlings BA, Han JK. Outcome results of endoscopic vs craniofacial resection of sinonasal malignancies: a systematic review and pooled-data analysis. Int Forum Allergy Rhinol 2011; 1 (04) 255-261
• 19 Lund VJ, Stammberger H, Nicolai P. et al; European Rhinologic Society Advisory Board on Endoscopic Techniques in the Management of Nose, Paranasal Sinus and Skull Base Tumours. European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base. Rhinol Suppl 2010; 22: 1-143
• 20 Robbins KT, Ferlito A, Silver CE. et al. Contemporary management of sinonasal cancer. Head Neck 2011; 33 (09) 1352-1365
• 21 Carrau RL, Segas J, Nuss DW. et al. Squamous cell carcinoma of the sinonasal tract invading the orbit. Laryngoscope 1999; 109 (2 Pt 1): 230-235
• 22 Sangal NR, Lee Y-J, Brady JS. et al. The role of elective neck dissection in the treatment of maxillary sinus squamous cell carcinoma. Laryngoscope 2018; 128 (08) 1835-1841
• 23 Guntinas-Lichius O, Kreppel MP, Stuetzer H, Semrau R, Eckel HE, Mueller RP. Single modality and multimodality treatment of nasal and paranasal sinuses cancer: a single institution experience of 229 patients. Eur J Surg Oncol 2007; 33 (02) 222-228